Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer

Cancer Research

Volumn 60, Issue 17, 2000, Pages 4850-4854

  Nagorsen, D ^a   Keilholz, U ^a   Rivoltini, L ^a   Schmittel, A ^a   Letsch, A ^a   Asemissen, A M ^a   Berger, G ^a   Buhr, H J ^a   Thiel, E ^a   Scheibenbogen, C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITHELIAL CELL ADHESION MOLECULE; EPITOPE; GAMMA INTERFERON; HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR IMMUNITY; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; MALE; METASTASIS; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; CELL ADHESION MOLECULES; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, T-LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; HLA-A2 ANTIGEN; HUMANS; LYMPHOCYTE ACTIVATION; MALE; NEOPLASM STAGING; PEPTIDE FRAGMENTS; RECEPTOR, ERBB-2; T-LYMPHOCYTES;

EID: 0034283019     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Tumor-infiltrating lymphocytes from human colon carcinomas. Functional and phenotypic characteristics after long-term culture in recombinant interleukin 2
2. Characterization of tumor-infiltrating lymphocytes derived from human tumors for use as adoptive immunotherapy of cancer
3. Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human caminoembryonic antigen
4. Colorectal cancer vaccines
5. Identification of potential HLA-A 0201 restricted CTL epitopes derived from the epithelial cell adhesion molecule (Ep-CAM) and the carcinoembryonic antigen (CEA)
6. Autoantibodies against the turnout-associated antigen GA733-2 in patients with colorectal carcinoma
7. The expression of p185(Her-2neu) correlates with the stage of disease and survival in colorectal cancer
8. Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER-2/neu-derived peptide
9. Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines
10. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes
11. Antibody immunity to the HER-2/neu oncogenic protein in patients with colorectal cancer
12. Colorectal cancer
13. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine
14. Detection and quantification of blood-derived CD8+ T lymphocytes secreting TNFα in response to HLA-A2.1-binding melanoma and viral peptide antigen
15. A sensitive Elispot assay for detection of CD8+ lymphocytes specific for HLA class I-binding peptide epimpes derived from influenza proteins in the blood of healthy donors and melanoma patients
16. Evaluation of the interferon-γ ELISPOT-assay of peptide-specific T lymphocytes from peripheral blood
17. The Her-2/neu-derived peptide p654-662 is a tumor-associated antigen in human pancreatic cancer recognized by cytotoxic T lymphocytes
18. Modulations of the effector function and cytokine production of human lymphocytes by secreted factors derived from colorectal-carcinoma cells
19. Gene transfer of costimulatory molecules into a human colorectal cancer cell line: Requirement of CD54 and CD80 and class II MHC expression for enhanced immuno-genicity
20. Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression
21. Interleukin 2 restores CD3-ζ chain expression but fails to generate tumour-specific lyric activity in tumour-infiltrating lymphocytes derived from human colorectal hepatic metastases
22. Phenotypical and functional separation of memory and effector human CD8+ T cells
23. Autoantibodies to tyrosinase: The bridge between melanoma and vitiligo
24. Antibody response against the c-erbB-2 oncoprotein in breast carcinoma patients
25. Humoral immune response of cancer patients against 'cancer-testis' antigen NY-ESO-1: Correlation with clinical events
26. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group
27. Tumor regression in monoclonal antibody-treated patients correlates with the presence of anti-idiotype-reactive T lymphocytes
28. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs